BMEA vs INCY · $94.7M cap vs P/E 14, rev $4.24B
Biomea Fusion Inc (BMEA) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
Incyte Corporation (INCY) is a biotechnology company listed on US.
BMEA does not have a complete income-statement cache yet.
Latest reported INCY revenue for 2024-12-31 was $4.24B. Net income was $32.6M. Revenue was up 14.8% from 2023-12-31 to 2024-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
BMEA currently screens at market cap $94.7M. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the BMEA and INCY stock pages for the full models.
Not investment advice.